Page last updated: 2024-10-22

anethole trithione and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

anethole trithione has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

Anethole Trithione: Choleretic used to allay dry mouth and constipation due to tranquilizers.

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LeVeque, FG1

Other Studies

1 other study available for anethole trithione and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
An unusual presentation of chronic graft-versus-host disease in an unrelated bone marrow transplantation.
    Oral surgery, oral medicine, and oral pathology, 1990, Volume: 69, Issue:5

    Topics: Adult; Ageusia; Anethole Trithione; Bone Marrow Transplantation; Chronic Disease; Graft vs Host Dise

1990